Clinical Trial Update: SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing the SOLX Gold Shunt to a control implant for refractory glaucoma has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Open-angle Glaucoma

Drugs mentioned

• SOLX Gold Shunt

Snippet

Sponsor: SOLX, Inc. | Conditions: Glaucoma, Glaucoma, Open Angle | Phase 3 | Status: SUSPENDED